Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design is a research paper published in Journal of Hepatology (2022). On theSindex it has a DataRank of 0.723. It has been cited 123 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.723
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK115594
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01AG034676
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R03DK128127
FWCI
16.18
Citation Percentile
1.0%
Influential Citations
6
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals